UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1951
Hertz
HTZ
$684M
| $3.04M | ﹤0.01% |
444,370
+107,247
| +32% | +$669K |
2023 Q1
9 quarters
|
|
1952
NETGEAR
NTGR
$641M
| $3.03M | ﹤0.01% |
104,399
+30,253
| +41% | +$813K |
2024 Q2
4 quarters
|
|
1953
First Majestic Silver
AG
$8.52B
| $3.03M | ﹤0.01% |
366,857
-826,732
| -69% | -$5.56M |
2024 Q2
4 quarters
|
|
1954
LGI Homes
LGIH
$1.02B
| $3.03M | ﹤0.01% |
58,761
+21,104
| +56% | +$1.15M |
2017 Q4
30 quarters
|
|
1955
BGC Group
BGC
$5.35B
| $3.02M | ﹤0.01% |
295,305
-417,061
| -59% | -$3.83M |
2013 Q2
48 quarters
|
|
1956
Blue Bird Corp
BLBD
$1.92B
| $3.02M | ﹤0.01% |
69,990
+20,933
| +43% | +$797K |
2023 Q1
9 quarters
|
|
1957
Cadre Holdings
CDRE
$1.05B
| $3.01M | ﹤0.01% |
94,651
+37,504
| +66% | +$1.21M |
2024 Q1
5 quarters
|
|
1958
Dave & Buster's
PLAY
$240M
| $3.01M | ﹤0.01% |
100,121
+12,772
| +15% | +$288K |
2015 Q2
40 quarters
|
|
1959
LXP Industrial Trust
LXP
$3.6B
| $2.99M | ﹤0.01% |
72,386
-2,229
| -3% | -$91.7K |
2013 Q2
48 quarters
|
|
1960
Independent Bank Corp
IBCP
$785M
| $2.98M | ﹤0.01% |
91,849
+20,734
| +29% | +$643K |
2018 Q1
29 quarters
|
|
1961
Redwood Trust
RWT
$398M
| $2.97M | ﹤0.01% |
502,334
+9,673
| +2% | +$55K |
2013 Q2
48 quarters
|
|
1962
Ultra Clean Holdings
UCTT
$3.11B
| $2.96M | ﹤0.01% |
131,256
+46,162
| +54% | +$948K |
2018 Q1
29 quarters
|
|
1963
Sprinklr
CXM
$1.28B
| $2.96M | ﹤0.01% |
349,420
+88,651
| +34% | +$710K |
2021 Q4
14 quarters
|
|
1964
Ocular Therapeutix
OCUL
$1.66B
| $2.94M | ﹤0.01% |
316,276
+103,324
| +49% | +$809K |
2024 Q2
4 quarters
|
|
1965
QuinStreet
QNST
$900M
| $2.93M | ﹤0.01% |
182,140
+68,774
| +61% | +$1.1M |
2018 Q2
28 quarters
|
|
1966
Geron
GERN
$790M
| $2.93M | ﹤0.01% |
2,078,625
+706,609
| +52% | +$1M |
2013 Q4
46 quarters
|
|
1967
Accendra Health
ACH
$32.9M
| $2.91M | ﹤0.01% |
319,590
+75,764
| +31% | +$558K |
2013 Q2
48 quarters
|
|
1968
Scansource
SCSC
$1.23B
| $2.91M | ﹤0.01% |
69,559
+8,046
| +13% | +$300K |
2013 Q2
48 quarters
|
|
1969
Vicor
VICR
$12.3B
| $2.91M | ﹤0.01% |
64,060
+22,519
| +54% | +$1.01M |
2019 Q1
25 quarters
|
|
1970
Compass Minerals
CMP
$957M
| $2.9M | ﹤0.01% |
144,536
+37,151
| +35% | +$600K |
2013 Q2
48 quarters
|
|
1971
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.9B
| $2.9M | ﹤0.01% |
77,265
| – | – |
2025 Q1
1 quarter
|
|
1972
Kiniksa Pharmaceuticals
KNSA
$6.22B
| $2.9M | ﹤0.01% |
104,705
+48,729
| +87% | +$1.24M |
2024 Q3
3 quarters
|
|
1973
iShares MSCI Global Gold Miners ETF
RING
$2.36B
| $2.9M | ﹤0.01% |
66,146
-9,102
| -12% | -$378K |
2025 Q1
1 quarter
|
|
1974
G-III Apparel Group
GIII
$1.16B
| $2.89M | ﹤0.01% |
128,874
+48,677
| +61% | +$1.23M |
2013 Q2
48 quarters
|
|
1975
Cable One
CABO
$63.2M
| $2.88M | ﹤0.01% |
21,207
+3,939
| +23% | +$739K |
2015 Q3
39 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.